Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) on Tuesday, soared 2.36% from the previous trading day ,before settling in for the closing price of $30.93. Within the past 52 weeks, ARCT’s price has moved between $17.52 and $43.81.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 310.16%. The company achieved an average annual earnings per share of -147.64%. With a float of $24.54 million, this company’s outstanding shares have now reached $26.83 million.
Considering the fact that the conglomerate employs 180 people, you should pay attention to its efficiency factor.
Arcturus Therapeutics Holdings Inc (ARCT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Arcturus Therapeutics Holdings Inc is 8.81%, while institutional ownership is 90.13%. The most recent insider transaction that took place on Mar 25 ’24, was worth 610,574. In this transaction Chief Scientific Officer & COO of this company sold 17,435 shares at a rate of $35.02, taking the stock ownership to the 473,448 shares. Before that another transaction happened on Mar 19 ’24, when Company’s Chief Scientific Officer & COO sold 8,565 for $35.01, making the entire transaction worth $299,839. This insider now owns 490,883 shares in total.
Arcturus Therapeutics Holdings Inc (ARCT) Recent Fiscal highlights
As on 12/30/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.32 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.99) by $0.67. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.89 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -147.64% per share during the next fiscal year.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Trading Performance Indicators
Arcturus Therapeutics Holdings Inc (ARCT) is currently performing well based on its current performance indicators. A quick ratio of 4.72 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.04, a number that is poised to hit 0.10 in the next quarter and is forecasted to reach 0.15 in one year’s time.
Technical Analysis of Arcturus Therapeutics Holdings Inc (ARCT)
Compared to the last year’s volume of 0.45 million, its volume of 0.52 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 35.11%. Additionally, its Average True Range was 2.05.
During the past 100 days, Arcturus Therapeutics Holdings Inc’s (ARCT) raw stochastic average was set at 51.57%, which indicates a significant increase from 32.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.35% in the past 14 days, which was lower than the 71.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $35.95, while its 200-day Moving Average is $29.89. Nevertheless, the first resistance level for the watch stands at $32.15 in the near term. At $32.63, the stock is likely to face the second major resistance level. The third major resistance level sits at $33.56. If the price goes on to break the first support level at $30.74, it is likely to go to the next support level at $29.81. Now, if the price goes above the second support level, the third support stands at $29.33.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Key Stats
Market capitalization of the company is 852.29 million based on 26,915K outstanding shares. Right now, sales total 166,800 K and income totals -29,730 K. The company made 30,860 K in profit during its latest quarter, and -11,710 K in sales during its previous quarter.
